Fluids Hypertension Syndromes: Migraines, Headaches, Normal ...

Fluids Hypertension Syndromes – Dr. Leonardo Izecksohn – page 343
ahead of print.
482. Nardone R, Ausserer H, Bratti A, Covi M, Lochner P, Marth R, Florio I, and Tezzon F. Trigeminocervical
reflex abnormalities in patients with migraine and cluster headache. Headache. 2008
Apr;48(4):578-85.
483. Nathanson, JA. Caffeine and related methylxanthines: possible naturally occurring pesticides. Science
226 (4671) October 12, 1984: 184-7. PMID 6207592.
484. National Institute on Deafness and Other Communication Disorders. National Institutes of Health.
FirstGov. 31 Center Drive, MSC 2320. Bethesda, MD USA 20892-23.
485. National Institute of Neurological Disorders and Stroke. Office of Communications and Public Liaison.
National Institutes of Health. Bethesda, MD 20892.
486. National Toxicology Program. U.S. Department of Health and Human Services; National Institutes
of Health's National Institute of Environmental Health Sciences. CERHR Home > Common
Concerns > Caffeine. Page last updated on 04/08/2005.
487. Nehlig A, Daval J L, and Debry G. Caffeine and the central nervous system: mechanism of action,
biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev. 1992 May-
Aug;17(2):139-70.
488. Nehlig A, and Debry G. Potential teratogenic and neurodevelopmental consequences of coffee and
caffeine exposure: a review on human and animal data. Neurotoxicol Teratol. 1994 Nov-
Dec;16(6):531-43.
489. Nelson S. Caffeine plus acetaminophen toxic for some. Chemical Research in Toxicology. 2007
Oct;15.
490. Nguyen C and Borruat FX. Bilateral peripapillary subretinal neovessel membrane associated with
chronic papilledema: report of two cases. Klin Monatsbl Augenheilkd. 2005 Mar;222(3):275-8.
491. Nicoletti P, Trevisani M, Manconi M, Gatti R, De Siena G, Zagli G, Benemei S, Capone J A, Geppetti
P, and Pini L A. Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release
in the trigeminovascular system of the guinea pig. Cephalalgia. 2008 Jan;28(1):9-17.
492. Nightingale S and Ray G S. Paradoxical embolism causing stroke and migraine. J Postgrad Med.
2010 Jul-Sep;56(3)206-8.
493. Nobrega J N, Barlow K L, Raymond R, and Richter A. Decreased adenosine receptor binding in
dystonic brains of the dt(sz) mutant. Neuroscience. 2005;134(1):33-8.
494. Nunnari G, Argyris E, Fang J, Mehlman K E, Pomerantz R J, and Daniel R. Virology. 2005 May
10;335(2):177-84.
495. O’Connell M B. Prevention and treatment of osteoporosis in the elderly. Pharmacotherapy. 1999
Jan;19(1 Pt 2):7S-20S.
496. Ohayon M M, Guilleminault C, Priest R G, and Caulet M. Snoring and breathing pauses during
sleep: telephone interview survey of a United Kingdom population sample. BMJ. 1997 Mar
22;314(7084):860-3.
497. Ohayon M M, Li K K, and Guilleminault C. Risk factors for sleep bruxism in the general population.
Chest.2001 Jan;119(1):53-61.
498. Ohta A, Gorelik E, Prasad S J, Ronchese F, Lukashev D, Wong M K K, Huang X, Caldwell S, Liu
K, Smith P, Chen J F, Jackson E K, Apasov S, Abrams S, and Sitkovsky M. A2A adenosine receptor
protects tumors from antitumor T cells. Proc Natl Acad Sci USA. 2006 Aug 29;103(35):13132-7.
499. Ohta A, and Sitkovsky M. The adenosinergic immunomodulatory drugs. Curr Opin Pharmacol.
2009 Jun 16. Epub ahead of print.
500. Ohta A, Lukashev D, Jackson E K, Fredholm B B, and Sitkovsky M. 1,3,7-trimethylxanthine (caffeine)
may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive
mechanism. J Immunol. 2007 Dec;179(11):7431-8.
501. Ohtsuka, K and Nakamura, Y. Open-angle glaucoma associated with Graves’ disease. American
Journal of Ophthalmology. 2000 May, 129(5):613-7.
502. Okano J, Nagahara T, Matsumoto K, and Murawaki Y. Caffeine inhibits the proliferation of liver
cancer cells and activate the MEK/ERK/EGFR signaling pathway. Basic Clin Pharmacol Toxicol.
2008 Mar 16 (Epub ahead of print).
503. Oksanen A, Erkintalo M, Metsahonkala L, Anttila P, Laimi K, Hiekkanen H, Salminen J J, Aro-